Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.30 -0.11 (-3.23%)
As of: Oct 21, 2026 · 10:18 AM EDT

Apimeds Pharmaceuticals US (APUS) Other Non-Current Assets (2025 - 2026)

Updated

Apimeds Pharmaceuticals US (APUS) reported Other Non-Current Assets of $33.15 million for Q2 2026, compared with $183,995 a year earlier.

Analysis

Apimeds Pharmaceuticals US (APUS) Other Non-Current Assets (2025 - 2026) Analysis & Trends

At the end of FY2025, Apimeds Pharmaceuticals US posted Other Non-Current Assets of $75,485.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,132.91 Bn 1,101.50 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 615.07 Bn 533.59 Bn 17.26 Bn 14.27 Bn
3 AbbVie 505.92 Bn 479.03 Bn 12.70 Bn 10.73 Bn
4 Merck 368.10 Bn 322.48 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 298.25 Bn 262.24 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 261.76 Bn 235.45 Bn 12.86 Bn -
7 Amgen 236.19 Bn 191.59 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn 4.75 Bn
9 Pfizer 170.37 Bn 117.02 Bn 10.94 Bn 9.94 Bn
10 Apimeds Pharmaceuticals US 5.70 Mn -13.94 Mn - 41.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.15 Mn
Dec 31, 2025 75,485.00
Sep 30, 2025 129,740.00
Jun 30, 2025 183,995.00
API Access

Apimeds Pharmaceuticals US Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=APUS&period=max&api_key=YOUR_API_KEY